DAIHAN PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28,800 KRW | +0.88% |
|
+0.70% | +3.78% |
| 2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
| 2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 213B 157M | Sales 2025 * | 233B 172M | Capitalization | 169B 125M |
|---|---|---|---|---|---|
| Net income 2024 * | 30B 22.17M | Net income 2025 * | 33B 24.39M | EV / Sales 2024 * | 0.15 x |
| Net cash position 2024 * | 138B 102M | Net cash position 2025 * | 163B 121M | EV / Sales 2025 * | 0.03 x |
| P/E ratio 2024 * |
5.61
x | P/E ratio 2025 * |
5.21
x | Employees | 553 |
| Yield 2024 * |
2.43% | Yield 2025 * |
2.52% | Free-Float | 59.32% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.88% | ||
| 1 week | +0.70% | ||
| Current month | +1.23% | ||
| 1 month | +2.49% | ||
| 3 months | -0.17% | ||
| 6 months | +4.35% | ||
| Current year | +3.78% |
1 week
28 400.00
29 300.00
1 month
28 000.0029 300.00
Current year
27 450.0029 650.00
1 year
25 500.0029 650.00
3 years
24 250.0036 700.00
5 years
21 950.0047 700.00
10 years
16 050.0052 700.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Seong-Soo Yoon
AUD | Comptroller/Controller/Auditor | 46 | 17-03-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Seung-Young Lee
BRD | Director/Board Member | 51 | 02-02-28 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 28,800 | +0.88% | 23,401 |
| 24-05-16 | 28,550 | -0.87% | 24,517 |
| 24-05-14 | 28,800 | 0.00% | 5,811 |
| 24-05-13 | 28,800 | +0.70% | 11,022 |
End-of-day quote Korea S.E., May 16, 2024
More quotes
DAIHAN PHARMACEUTICAL CO.,LTD. is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides infusions, including basic infusions, nutritional infusions and infusions for special uses; injections for anesthetics, vitamin-minerals, autonomic nerve systems, hypnotic-sedatives, antispasmodics, antidotes, hormones, analgesics, respiratory and others; contrast media, such as drugs for computed tomography (CT) uses and magnetic resonance imaging (MRI) uses, and other drugs, such as drugs for irrigations, ointments, inhalants, as well as quasi-drugs such as hand gels, lens clean solutions and others.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.78% | 125M | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
- Stock Market
- Equities
- A023910 Stock